As treatment protocols for medulloblastoma (MB) are becoming subgroup-specific, means for reliably distinguishing between its subgroups are a timely need. Currently available methods include immunohis
BackgroundNext-generation sequencing (NGS) panels for mature B-cell neoplasms (MBNs) are widely applied clinically but have yet to be routinely used in a manner that is suitable for subtype differenti
DLBCL indicates diffuse large B-cell lymphoma; MCL, mantle cell lymphoma; new, a diagnosis of lymphoma with no previous history of lymphoproliferative disease; MZL, marginal zone lymphoma; and SLL, sm